Prioritize protein and hydration in the first weeks
Terms to know GLP-1 RA (Glucagon-like peptide-1 receptor agonists): These therapies mimic the bodys natural GLP-1 hormone to regulate blood sugar and promote feelings of fullness
Risks include: Contamination from improper handling or manufacturing Incorrect dosing leading to overdose or lack of effect Unknown ingredients or mislabeled products Dangerous side effects without medical monitoring Mental Health Risks of Unregulated GLP-1 Use At Montare, we treat many patients whose mental health conditions are worsened by unregulated medication use
These areas are influenced by different peripheral signals coming from the liver and gut, the endocrine pancreas and the adipocytes, which could act directly on neurons in the CNS or through afferent neurons
It targets specific parts of your brain that control hunger, making you feel fuller longer and reducing those cravings
In a study published in 2018 called the SUSTAIN-7 trial, semaglutide was compared to dulaglutide in treating type 2 diabetes